Psychedelic and Plant Medicine Therapists, Practitioners, Providers

26 readers

1 users here now

Providers trained in psychedelic therapies, medicines and traditional practice. No sourcing of compounds.

founded 11 months ago

MODERATORS

PlanetMedicines

LSD Effective in Treating Anxiety, Phase II Clinical Trial Shows (2024) (cannadelics.com)

submitted 11 months ago by PlanetMedicines to c/psychedelic_practitioners

1 comments fedilink hide all child comments

you are viewing a single comment's thread
view the rest of the comments

[–] doppelgangmember 1 points 10 months ago* (last edited 10 months ago)

Yay!

So it's MindMed using their own analog of LSD-25 called MM-120 (lysergide d-tartrate)

"MM-120 (lysergide d-tartrate) is a new drug developed by MindMed, a biotech company the focuses on psychedelic-based medications. This drug is a “new and improved” version of LSD that is currently undergoing clinical trials for the treatment of generalized anxiety disorder (GAD). The most recent results from phase II of testing found that the drug candidate, particularly at the 100 µg dose, “demonstrated effectiveness, significantly reducing anxiety symptoms.”"

... without psychotherapy, which is HUGE

"MM-120 is the closest we’ve ever had to a clinically-proven and FDA-approved LSD-based medication. Phase II trials are currently underway, so it’s well on the path to becoming available via prescriptions in select markets, although it could still be some time before we can expect more widespread use of this drug. "